Randomised, double-blind, placebo controlled trial of lithium carbonate for the management of human cannabis withdrawal

该项目旨在通过探索锂的安全性和有效性来帮助依赖大麻的使用者停止使用大麻，以降低在停止使用时发生的戒断严重程度。参与者将在住院药物治疗单元(悉尼或利斯莫尔)住7天，并将被随机分配接受锂或安慰剂。接受锂治疗的参与者预计在后续行动中戒断程度较轻，对大麻的戒断率较高。

This project aims to help dependent cannabis users stop using cannabis by exploring the safety and effectiveness of lithium in reducing the severity of withdrawal that occurs on cessation of use. Participants will be admitted to an inpatient drug treatment unit (Sydney or Lismore) for 7 days and will be randomly assigned to receive either lithium or placebo. Participants receiving lithium are expected to have less severe withdrawal and higher rates of abstinence from cannabis at follow-up.